QTTB — Q32 Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapTurnaround

Annual balance sheet for Q32 Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	156	175	82.7	78	48.3
Net Total Receivables	—	—	—	0.555	0.555
Prepaid Expenses
Total Other Current Assets
Total Current Assets	192	181	83.9	81.9	55
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.9	21.6	0.65	7.09	6.08
Long Term Investments
Other Long Term Assets
Total Assets	212	228	84.6	92.3	61.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.2	22.6	11.6	16.5	11.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	42.1	50.5	11.6	86.7	19.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	170	178	73	5.67	42
Total Liabilities & Shareholders' Equity	212	228	84.6	92.3	61.8
Total Common Shares Outstanding